Patent classifications
C
C12
C12N
2770/00
C12N2770/00011
C12N2770/18011
C12N2770/18032
C12N2770/18032
VLP IMMUNOTHERAPY COMBINED WITH ABLATION
20250017991
·
2025-01-16
·
Provided herein is a novel, multimodal in situ vaccination approach to treat cancer by combining ablation with administration of the naturally occurring plant virus or virus-like particle (VLP) nanoparticles such as cowpea mosaic virus (CPMV), a plant virus-based immunoadjuvant.